Prenalterol
CAS: 57526-81-5
Ref. 3D-FP27157
2mg | 136,00 € | ||
5mg | 206,00 € | ||
10mg | 346,00 € | ||
25mg | 582,00 € | ||
50mg | 925,00 € |
Informação sobre produto
- 4-[(2S)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]phenol(-)-Prenalterol(S)-Prenalterol
- (-)-(S)-1-(p-Hydroxyphenoxy)-3-(isopropylamino)-2-propanol
- (S)-4-(2-Hydroxy-3-(isopropylamino)propoxy)phenol
- (S)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]phenol
- (S)-Prenalterol
- 260-791-5
- 4-[(2S)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]phenol
- 4-[2-Hydroxy-3-(Propan-2-Ylamino)Propoxy]Phenol
- 4-{[(2S)-2-hydroxy-3-(propan-2-ylamino)propyl]oxy}phenol
- Cgp 7760B
- Ver mais sinónimos
- H 133/22
- Hyprenan
- Phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, (S)-
- Phenol, 4-[(2S)-2-hydroxy-3-[(1-methylethyl)amino]propoxy]-
- S-Varbian
- phenol, 4-[[(2S)-2-hydroxy-3-[(1-methylethyl)amino]propyl]oxy]-
Prenalterol is a drug that can be used to treat congestive heart failure and high blood pressure. It belongs to the class of 2-adrenergic receptor agonists, which are drugs that stimulate the sympathetic nervous system. Prenalterol has been shown to have a positive effect on the cardiovascular system by increasing cardiac output. This drug also has an anti-inflammatory effect, which may be due to its ability to inhibit protein synthesis genes in cells. Prenalterol has also been shown to reduce post-myocardial infarction remodeling by reducing myocardial fibrosis, although it does not affect the incidence of myocardial infarcts.
Propriedades químicas
Consulta técnica sobre: 3D-FP27157 Prenalterol
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.